Optimum Investment Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40
Closed -$10K 851
2022
Q3
$10K Hold
40
0.01% 593
2022
Q2
$10K Hold
40
0.01% 610
2022
Q1
$13K Sell
40
-75
-65% -$23.1K 0.01% 623
2021
Q4
$41K Hold
115
0.02% 502
2021
Q3
$37K Hold
115
0.02% 510
2021
Q2
$36K Sell
115
-50
-30% -$15.3K 0.01% 579
2021
Q1
$53K Hold
165
0.02% 493
2020
Q4
$53K Sell
165
-150
-48% -$41.5K 0.02% 468
2020
Q3
$87K Sell
315
-10
-3% -$2.88K 0.03% 351
2020
Q2
$79K Hold
325
0.03% 360
2020
Q1
$47K Hold
325
0.02% 443
2019
Q4
$55K Hold
325
0.02% 502
2019
Q3
$58K Hold
325
0.02% 488
2019
Q2
$85K Hold
325
0.03% 405
2019
Q1
$93K Hold
325
0.03% 393
2018
Q4
$106K Buy
325
+300
+1,200% +$104K 0.04% 356
2018
Q3
$11K Buy
+25
New +$9.86K ﹤0.01% 833

Other funds holding ABMD

Optimum Investment Advisors's ABMD Position: Q4 2022 in Review

Optimum Investment Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 40 shares — an estimated $10K sold.

Optimum Investment Advisors first reported a position in ABMD in Q3 2018 and held it in 17 quarters. The position peaked at $106K in Q4 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Optimum Investment Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Optimum Investment Advisors sold 40 Abiomed Inc shares in Q4 2022, an estimated $10K.
  • Optimum Investment Advisors first reported a position in Abiomed Inc in Q3 2018 and held it in 17 quarters.
  • Optimum Investment Advisors's Abiomed Inc position peaked at $106K in Q4 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Optimum Investment Advisors's 13F filing for Q4 2022, filed 5 Jan 2023.